During the past decade, New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders" #1 collaborator was "Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders" are "Recurrent Childhood Ependymoma" (1 trials), "Recurrent or Progressive Low-grade Glioma" (1 trials), "Recurrent or Progressive Optic Pathway Gliomas (OPG)" (1 trials) and "neurofibromatosis1 (NF1)" (1 trials). Many other conditions were trialed in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders" in a lesser frequency.

Most popular intervention types in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Everolimus" (1 trials) and "Sorafenib (Nexavar)" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".